The Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement
The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of Louisiana. Xarelto is an anticoagulant used to prevent the … [Read more...]
Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny
According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner caused irreversible bleeding, because Xarelto lacks an antidote. … [Read more...]
Xarelto Lawsuits Have Added Credibility Based on Scholarly Studies
The makers of Xarelto, an anticoagulant that was credited as a breakthrough in blood clot prevention, is battling numerous lawsuits. An alleged connection between an elevated risk for serious hemorrhages and Xarelto are now being lent possible increased credibility through recent studies, reports the Digital Journal. The U.S. Food … [Read more...]
